产品简要
公司名称 :
Novus Biologicals
其他品牌 :
IMGENEX
产品类型 :
抗体
产品名称 :
CHREBP Antibody - BSA Free
目录 :
NB400-135
规格 :
0.1 ml (also 0.025 ml)
价格 :
449美元
克隆性 :
多克隆
宿主 :
domestic rabbit
共轭标签 :
未共轭
反应物种 :
人类, 小鼠, 大鼠
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 免疫沉淀, EMSA, 染色质免疫沉淀 , 免疫组化-石蜡切片, 免疫印迹基因敲除验证
更多信息或购买 :
文章摘录数: 80
出版应用/物种/样本/稀释参考文献
  • 免疫印迹; 小鼠; 图 6a
Carroll P, Freie B, Cheng P, Kasinathan S, Gu H, Hedrich T, et al. The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis. PLoS Biol. 2021;19:e3001085 pubmed 出版商
  • 免疫印迹基因敲除验证; 小鼠; 图 s4d
Schlein C, Fischer A, Sass F, Worthmann A, Tödter K, Jaeckstein M, et al. Endogenous Fatty Acid Synthesis Drives Brown Adipose Tissue Involution. Cell Rep. 2021;34:108624 pubmed 出版商
  • 免疫组化-石蜡切片; 小鼠; 图 6b
  • 免疫印迹; 人类; 图 2b
Na T, Kim G, Oh H, Lee M, Han Y, Kim K, et al. The trisaccharide raffinose modulates epidermal differentiation through activation of liver X receptor. Sci Rep. 2017;7:43823 pubmed 出版商
van den Berg L, Kokki K, Wowro S, Petricek K, Deniz O, Stegmann C, et al. Sugar-responsive inhibition of Myc-dependent ribosome biogenesis by Clockwork orange. Cell Rep. 2023;42:112739 pubmed 出版商
Gu L, Zhu Y, Watari K, Lee M, Liu J, Pérez S, et al. Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness. Cell Metab. 2023;35:1009-1021.e9 pubmed 出版商
Yao L, Wang M, Zhang J, Luo X, Yuan C, Bai R, et al. Oleanolic Acid Inhibits SCD1 Gene Expression to Ameliorate Fructose-Induced Hepatosteatosis through SREBP1c-Dependent and -Independent Mechanisms. Mol Nutr Food Res. 2023;67:e2200533 pubmed 出版商
Senatus L, Ega xf1 a Gorro xf1 o L, L xf3 pez D xed ez R, Bergaya S, Aranda J, Amengual J, et al. DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice. Commun Biol. 2023;6:280 pubmed 出版商
Ma Y, Shen S, Yan Y, Zhang S, Liu S, Tang Z, et al. Adipocyte Thyroid Hormone β Receptor-Mediated Hormone Action Fine-tunes Intracellular Glucose and Lipid Metabolism and Systemic Homeostasis. Diabetes. 2023;72:562-574 pubmed 出版商
Sargsyan A, Doridot L, Hannou S, Tong W, Srinivasan H, Ivison R, et al. HGFAC is a ChREBP-regulated hepatokine that enhances glucose and lipid homeostasis. JCI Insight. 2023;8: pubmed 出版商
Oh A, Jeong Y, Yu J, Minh Tam D, Kang J, Jung Y, et al. Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization. Gastroenterology. 2023;164:439-453 pubmed 出版商
Katz L, Argmann C, Lambertini L, Scott D. T3 and glucose increase expression of phosphoenolpyruvate carboxykinase (PCK1) leading to increased β-cell proliferation. Mol Metab. 2022;66:101646 pubmed 出版商
Stephenson E, Stayton A, Sethuraman A, Rao P, Meyer A, Gomes C, et al. Chronic intake of high dietary sucrose induces sexually dimorphic metabolic adaptations in mouse liver and adipose tissue. Nat Commun. 2022;13:6062 pubmed 出版商
Thevkar Nagesh P, Habault J, Voisin M, Ruff S, Ha S, Ruoff R, et al. Transcriptional regulation of Acsl1 by CHREBP and NF-kappa B in macrophages during hyperglycemia and inflammation. PLoS ONE. 2022;17:e0272986 pubmed 出版商
Katz L, Brill G, Zhang P, Kumar A, Baumel Alterzon S, Honig L, et al. Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure. Nat Commun. 2022;13:4423 pubmed 出版商
Zhang J, Zhang J, Fu Z, Zhang Y, Luo Z, Zhang P, et al. CHREBP suppresses gastric cancer progression via the cyclin D1-Rb-E2F1 pathway. Cell Death Discov. 2022;8:300 pubmed 出版商
Wu H, Lin C, Pai H, Chen Y, Cheng K, Kuo H, et al. Sucralose, a Non-nutritive Artificial Sweetener Exacerbates High Fat Diet-Induced Hepatic Steatosis Through Taste Receptor Type 1 Member 3. Front Nutr. 2022;9:823723 pubmed 出版商
Kim D, Nam G, Seo E, Jun H. Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells. J Biomed Sci. 2022;29:31 pubmed 出版商
Shibuya K, Ebihara K, Ebihara C, Sawayama N, Isoda M, Yamamuro D, et al. AAA-ATPase valosin-containing protein binds the transcription factor SREBP1 and promotes its proteolytic activation by rhomboid protease RHBDL4. J Biol Chem. 2022;298:101936 pubmed 出版商
Balamurugan K, Medishetti R, Kotha J, Behera P, Chandra K, Mavuduru V, et al. PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways. iScience. 2022;25:103766 pubmed 出版商
Gu W, Wang X, Zhao H, Geng J, Li X, Zheng K, et al. Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway. Eur J Pharmacol. 2022;918:174776 pubmed 出版商
Recazens E, Tavernier G, Dufau J, Bergoglio C, Benhamed F, Cassant Sourdy S, et al. ChREBPβ is dispensable for the control of glucose homeostasis and energy balance. JCI Insight. 2022;7: pubmed 出版商
Yenilmez B, Wetoska N, Kelly M, Echeverria D, Min K, Lifshitz L, et al. An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis. Mol Ther. 2022;30:1329-1342 pubmed 出版商
Mendoza A, Tang C, Choi J, Acuña M, Logan M, Martin A, et al. Thyroid hormone signaling promotes hepatic lipogenesis through the transcription factor ChREBP. Sci Signal. 2021;14:eabh3839 pubmed 出版商
Chen N, Song S, Yang Z, Wu M, Mu L, Zhou T, et al. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy. J Diabetes Complications. 2021;35:108050 pubmed 出版商
Liu Y, Zienkiewicz J, Boyd K, Smith T, Xu Z, Hawiger J. Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles. Sci Rep. 2021;11:11907 pubmed 出版商
Mori H, Dugan C, Nishii A, Benchamana A, Li Z, Cadenhead T, et al. The molecular and metabolic program by which white adipocytes adapt to cool physiologic temperatures. PLoS Biol. 2021;19:e3000988 pubmed 出版商
Youn D, Xiaoli A, Zong H, Okada J, Liu L, Pessin J, et al. The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc). Mol Metab. 2021;48:101227 pubmed 出版商
Gutierrez J, Liu W, Perez S, Xing G, SONNENBERG G, Kou K, et al. Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction. Mol Metab. 2021;48:101196 pubmed 出版商
Lu Y, Tian N, Hu L, Meng J, Feng M, Zhu Y, et al. ERα down-regulates carbohydrate responsive element binding protein and decreases aerobic glycolysis in liver cancer cells. J Cell Mol Med. 2021;25:3427-3436 pubmed 出版商
Velázquez Villegas L, Noriega L, López Barradas A, Tobon Cornejo S, Méndez García A, Tovar A, et al. ChREBP downregulates SNAT2 amino acid transporter expression through interactions with SMRT in response to a high-carbohydrate diet. Am J Physiol Endocrinol Metab. 2021;320:E102-E112 pubmed 出版商
Hsiao W, Jung S, Tang Y, Haley J, Li R, Li H, et al. The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. Cell Rep. 2020;33:108223 pubmed 出版商
Heidenreich S, WEBER P, Stephanowitz H, Petricek K, Schütte T, Oster M, et al. The glucose-sensing transcription factor ChREBP is targeted by proline hydroxylation. J Biol Chem. 2020;295:17158-17168 pubmed 出版商
Morigny P, Houssier M, Mairal A, Ghilain C, Mouisel E, Benhamed F, et al. Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity. Nat Metab. 2019;1:133-146 pubmed 出版商
Long J, Galvan D, Mise K, Kanwar Y, Li L, Poungvarin N, et al. Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1. J Biol Chem. 2020;: pubmed 出版商
Fan Q, Nørgaard R, Grytten I, Ness C, Lucas C, Vekterud K, et al. LXRα Regulates ChREBPα Transactivity in a Target Gene-Specific Manner through an Agonist-Modulated LBD-LID Interaction. Cells. 2020;9: pubmed 出版商
Bagchi D, Li Z, Corsa C, Hardij J, Mori H, Learman B, et al. Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction. Mol Metab. 2020;39:100992 pubmed 出版商
Tong X, Zhang D, Shabandri O, Oh J, Jin E, Stamper K, et al. DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1. Metabolism. 2020;107:154222 pubmed 出版商
Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L, et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature. 2020;579:586-591 pubmed 出版商
Wei C, Ma X, Su K, Qi S, Zhu Y, Lin J, et al. ChREBP-β regulates thermogenesis in brown adipose tissue. J Endocrinol. 2020;245:343-356 pubmed 出版商
Lei Y, Zhou S, Hu Q, Chen X, Gu J. Carbohydrate response element binding protein (ChREBP) correlates with colon cancer progression and contributes to cell proliferation. Sci Rep. 2020;10:4233 pubmed 出版商
Zhao C, Liu L, Liu Q, Li F, Zhang L, Zhu F, et al. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Mol Metab. 2019;29:145-157 pubmed 出版商
Lane E, Choi D, Garcia Haro L, Levine Z, Tedoldi M, Walker S, et al. HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP. Mol Cell. 2019;: pubmed 出版商
Van Der Werf R, Walter C, Bietiger W, Seyfritz E, Mura C, Péronet C, et al. Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. Cardiovasc Diabetol. 2018;17:104 pubmed 出版商
Bricambert J, Alves Guerra M, Esteves P, Prip Buus C, Bertrand Michel J, Guillou H, et al. The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun. 2018;9:2092 pubmed 出版商
Kumar A, Katz L, Schulz A, Kim M, Honig L, Li L, et al. Activation of Nrf2 Is Required for Normal and ChREBPα-Augmented Glucose-Stimulated β-Cell Proliferation. Diabetes. 2018;67:1561-1575 pubmed 出版商
Singh K, Kim S, Hahm E, Pore S, Jacobs B, Singh S. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Carcinogenesis. 2018;39:826-837 pubmed 出版商
Linden A, Li S, Choi H, Fang F, Fukasawa M, Uyeda K, et al. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J Lipid Res. 2018;59:475-487 pubmed 出版商
Kim M, Astapova I, Flier S, Hannou S, Doridot L, Sargsyan A, et al. Intestinal, but not hepatic, ChREBP is required for fructose tolerance. JCI Insight. 2017;2: pubmed 出版商
Sanchez Gurmaches J, Tang Y, Jespersen N, Wallace M, Martinez Calejman C, Gujja S, et al. Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis. Cell Metab. 2018;27:195-209.e6 pubmed 出版商
Katz L, Xu S, Ge K, Scott D, Gershengorn M. T3 and Glucose Coordinately Stimulate ChREBP-Mediated Ucp1 Expression in Brown Adipocytes From Male Mice. Endocrinology. 2018;159:557-569 pubmed 出版商
Kim Y, Kim M, Choi M, Lee D, Roh G, Kim H, et al. Aralia elata (Miq) Seem Extract Decreases O-GlcNAc Transferase Expression and Retinal Cell Death in Diabetic Mice. J Med Food. 2017;20:989-1001 pubmed 出版商
Iroz A, Montagner A, Benhamed F, Levavasseur F, Polizzi A, Anthony E, et al. A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response. Cell Rep. 2017;21:403-416 pubmed 出版商
Kwon J, Lee Y, Cho J, Kim G, Anduaga J, Starost M, et al. Liver-directed gene therapy for murine glycogen storage disease type Ib. Hum Mol Genet. 2017;26:4395-4405 pubmed 出版商
Softic S, Gupta M, Wang G, Fujisaka S, O Neill B, Rao T, et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J Clin Invest. 2017;127:4059-4074 pubmed 出版商
Heidenreich S, Witte N, WEBER P, Goehring I, Tolkachov A, von Loeffelholz C, et al. Retinol saturase coordinates liver metabolism by regulating ChREBP activity. Nat Commun. 2017;8:384 pubmed 出版商
Kim Y, Kim M, Choi M, Lee D, Roh G, Kim H, et al. Metformin protects against retinal cell death in diabetic mice. Biochem Biophys Res Commun. 2017;492:397-403 pubmed 出版商
Ducheix S, Montagner A, Polizzi A, Lasserre F, Régnier M, Marmugi A, et al. Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling. PLoS ONE. 2017;12:e0181393 pubmed 出版商
Fan Q, Nørgaard R, Bindesbøll C, Lucas C, Dalen K, Babaie E, et al. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice. Nutrients. 2017;9: pubmed 出版商
Cho J, Kim G, Pan C, Anduaga J, Choi E, Mansfield B, et al. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet. 2017;13:e1006819 pubmed 出版商
Janssens S, Ciapaite J, Wolters J, van Riel N, Nicolay K, Prompers J. An In Vivo Magnetic Resonance Spectroscopy Study of the Effects of Caloric and Non-Caloric Sweeteners on Liver Lipid Metabolism in Rats. Nutrients. 2017;9: pubmed 出版商
Irimia J, Meyer C, Segvich D, Surendran S, DePaoli Roach A, Morral N, et al. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice. J Biol Chem. 2017;292:10455-10464 pubmed 出版商
Kim G, Kwon J, Cho J, Zhang L, Mansfield B, Chou J. Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. Hum Mol Genet. 2017;26:1890-1899 pubmed 出版商
Al Oanzi Z, Fountana S, Moonira T, Tudhope S, Petrie J, Alshawi A, et al. Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes. Diabetes Obes Metab. 2017;19:1078-1087 pubmed 出版商
Cao W, Chang T, Li X, Wang R, Wu L. Dual effects of fructose on ChREBP and FoxO1/3α are responsible for AldoB up-regulation and vascular remodelling. Clin Sci (Lond). 2017;131:309-325 pubmed 出版商
McMurphy T, Huang W, Xiao R, Liu X, Dhurandhar N, Cao L. Hepatic Expression of Adenovirus 36 E4ORF1 Improves Glycemic Control and Promotes Glucose Metabolism Through AKT Activation. Diabetes. 2017;66:358-371 pubmed 出版商
Kim M, Krawczyk S, Doridot L, Fowler A, Wang J, Trauger S, et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest. 2016;126:4372-4386 pubmed 出版商
Harris K, Desai N, Gupta M, Xue X, Chatterjee P, Rochelson B, et al. The effects of prenatal metformin on obesogenic diet-induced alterations in maternal and fetal fatty acid metabolism. Nutr Metab (Lond). 2016;13:55 pubmed 出版商
Schmidt S, Madsen J, Frafjord K, Poulsen L, Salö S, Boergesen M, et al. Integrative Genomics Outlines a Biphasic Glucose Response and a ChREBP-ROR? Axis Regulating Proliferation in ? Cells. Cell Rep. 2016;16:2359-72 pubmed 出版商
Marmugi A, Lukowicz C, Lasserre F, Montagner A, Polizzi A, Ducheix S, et al. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way. Toxicol Appl Pharmacol. 2016;303:90-100 pubmed 出版商
Tang Y, Wallace M, Sanchez Gurmaches J, Hsiao W, Li H, Lee P, et al. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat Commun. 2016;7:11365 pubmed 出版商
Kitsunai H, Makino Y, Sakagami H, Mizumoto K, Yanagimachi T, Atageldiyeva K, et al. High glucose induces platelet-derived growth factor-C via carbohydrate response element-binding protein in glomerular mesangial cells. Physiol Rep. 2016;4: pubmed 出版商
Zhang Z, Li B, Meng X, Yao S, Jin L, Yang J, et al. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Sci Rep. 2016;6:20848 pubmed 出版商
Nuotio Antar A, Poungvarin N, Li M, Schupp M, Mohammad M, Gerard S, et al. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Endocrinology. 2015;156:4020-32 pubmed 出版商
Witte N, Muenzner M, Rietscher J, Knauer M, Heidenreich S, Nuotio Antar A, et al. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation. Endocrinology. 2015;156:4008-19 pubmed 出版商
Li X, Kover K, Heruth D, Watkins D, Moore W, Jackson K, et al. New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells. Mol Endocrinol. 2015;29:1184-94 pubmed 出版商
Trabelsi M, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin S, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6:7629 pubmed 出版商
Marmier S, Dentin R, Daujat Chavanieu M, Guillou H, Bertrand Michel J, Gerbal Chaloin S, et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology. 2015;62:1086-100 pubmed 出版商
Poungvarin N, Chang B, Imamura M, Chen J, Moolsuwan K, Sae Lee C, et al. Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin. Endocrinology. 2015;156:1982-94 pubmed 出版商
Bindesbøll C, Fan Q, Nørgaard R, MacPherson L, Ruan H, Wu J, et al. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J Lipid Res. 2015;56:771-85 pubmed 出版商
Kaadige M, Yang J, Wilde B, Ayer D. MondoA-Mlx transcriptional activity is limited by mTOR-MondoA interaction. Mol Cell Biol. 2015;35:101-10 pubmed 出版商
产品信息
品牌 :
Novus Biologicals, a Bio-Techne Brand
catalog number base :
NB400-135
SKU号 :
NB400-135
产品名称 :
CHREBP Antibody - BSA Free
描述 :
The CHREBP Antibody - BSA Free from Novus is a rabbit polyclonal antibody to CHREBP. This antibody reacts with human, mouse, rat. The CHREBP Antibody - BSA Free has been validated for the following applications: Western Blot, Chromatin Immunoprecipitation, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunoblotting, Gel Super Shift Assays, SDS-Page, Chromatin Immunoprecipitation (ChIP), Knockout Validated.
靶标 :
CHREBP
类别 :
一抗
单位尺寸 :
0.1 ml (also 0.025 ml)
缓冲液 :
PBS
克隆性 :
多克隆
浓度 :
1毫克/毫升
共轭标签 :
未共轭
宿主 :
免疫原 :
A C-terminal synthetic peptide made to the human CHREBP protein sequence (between residues 800-852). [UniProt# Q9NP71, Isoform 1/Alpha]
抗体亚型 :
IgG
纯度 :
免疫原亲和纯化
物种 :
人类, 小鼠, 大鼠
理论上的分子量 :
95 kDa
基因符号 :
MLXIPL
应用 :
Western Blot, Chromatin Immunoprecipitation, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunoblotting, Gel Super Shift Assays, SDS-Page, Chromatin Immunoprecipitation (ChIP), Knockout Validated
美元 :
449美元
别名 :
BHLHD14, CHREBPcarbohydrate-responsive element-binding protein, Class D basic helix-loop-helix protein 14, MIOWS basic-helix-loop-helix leucine zipper protein, MLX interacting protein-like, MLX interactor, MLX-interacting protein-like, MONDOBWilliams-Beuren syndrome chromosomal region 14 protein, WBSCR14Williams-Beuren syndrome chromosome region 14 protein 1, Williams Beuren syndrome chromosome region 14, Williams-Beuren syndrome chromosome region 14 protein 2, WS-bHLHbHLHd14carbohydrate response element binding protein
储存 :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
更多信息或购买 :
公司信息
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
technical@novusbio.com
https://www.novusbio.com
1-888-506-6887 303-730-1950
公司总部: 美国
Novus Biologicals的任务是开发最先进的新产品及市场行销来加速生物科研的新发现。藉由高效率的组织分工,Novus Biologicals建立了一个将生物学术团体的成果快速商品化的平台。我们的产品除了附有详细的产品资讯外,Novus Biologicals更提供完整的技术支援及服务。利用快速有效的市场通路以便迅速提供所有的科研学者最先进的研究试剂,Novus Biologicals扮演市场上重要的角色。